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This article reviews data from experimental and epidemiologic studies on passive smoking and makes
12 recommendations for further study. The physicochemical nature of passive smoke, the smoke inhaled
by nonsmokers, differs significantly from the mainstream smoke inhaled by the active smoker. At present,
measurement ofurinary cotinine appears to be the best method ofassessing exposures to passive smoking.
Data indicate that the greater number of lung cancers in nonsmoking women is probably related to
environmental tobacco smoke. Exposures in utero and very early in life to passive smoking may be
important in relationship to the subsequent development of cancer and need further consideration. The
short-term effects ofenvironmental tobacco smoke on the cardiovascular system, especially among high-
risk individuals, may be of greater concern than that ofcancer and requires further study. Further study
of increased risks of lung cancers in relation to environmental tobacco smoke exposure requires larger
collaborative studies to identify lung cancer cases among nonsmokers, better delineation of pathology,
and more careful selection of controls. In addition, studies of epithelial cells or specific cytology should
be undertaken to determine evidence of cellular changes in relation to environmental tobacco smoke
exposure. Animal inhalation studies with passive smoke should be initiated with respect to transplacental
carcinogenesis, the relationship of sidestream smoke exposure with lung cancer, the induction oftumors
in the respiratory tract and other organs, and the differences in the physicochemical natures ofsidestream
and mainstream smoke.
Tobacco smoke affects notonlypeople who smoke but
also nonsmokers who are exposed to the environmental
pollutants that are generated when tobacco products
are burned. Sidestream smoke (SS), which is emitted
from the tobacco products during puff intervals, con-
stitutes the major source of such pollutants. Some of
the mainstream smoke (MS) which escapes into the en-
vironment from the mouthpiece ofthe cigarette, cigar,
or pipe after drawing a puff and that portion of the
smoke exhaled by the smoker are further contributors
to indoor air pollution. The exposure ofnonsmokers to
environmental tobacco smoke pollutants is also known
as "passive smoking."
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Sidestream Smoke
The composition of SS differs significantly from that
of MS. The SS generated between puff-drawing origi-
nates from a hydrogen-enriched, strongly reducing at-
mosphere. It contains, therefore, more combustion
products than MS formed as a result of oxygen defi-
ciency and thermal cracking. In addition, SS formation
involvesgenerationoflargerquantitiesofreactionprod-
ucts of nitrates.
Table 1 compares MS and SSfrom an85-mmnonfilter
cigarette (1). These two tobacco combustion products
are generated at distinctly different temperatures, and
particle sizes in MS (0.1-1.O,um) are about 10 times
those in SS (0.01-0.lium). This suggests that, upon in-
halation, SS particles reach the more distant alveolar
spaces of the lung to a greater extent than do the MS
particles (2). Above pH 6, increasing amounts of un-
protonated nicotine are present in the smoke. There-
fore, SS (pH 6.4-6.6) contains more free nicotine in the
gas phase than MS (3).
About 300 to 400 of the more than 3800 individual
compounds identified in tobacco smoke have been quan-
titatively determined in both MS and SS. Ratios >1.0KULLER ET AL.
Table 1. Comparisons of mainstream (MS) and sidestream (SS)
smoke of cigarettes (physicochemical data).a
MS SS
Parameters
Peak temperature during =900 =600
formation, °C
pH (total aerosol)b 6.0-6.2 6.4-6.6
Particle size, ,um 0.1-1.0 0.01-0.1
Median diameter, urm 0.4
Smoke dilution (vol. %)C
Carbon monoxide 3-5 ==1
Carbon dioxide 8-11 =2
Oxygen 12-16 16-20
Hydrogen 15-3 =0.5
aFrom Hoffmann et al. (12) by permission.
bFor 85 mm nonfilter cigarette.
cAt 10 mm distance from the burning coal.
in Table 2 (4) show that more of a given compound is
released into SS than into MS. However, it must be
realized that, in general, exposure to SS occurs after
considerable air dilution, while the MS of cigarettes is
inhaled without major dilution.
The first part of Table 2 focuses on a comparison of
a few volatile compounds in MS and SS. On the basis
ofthe amount oftobacco burned duringthe smouldering
ofa cigarette without filter tip, SS to MS ratios should
be between 1.3 to 1.7. This calculation is based on the
assumption that the combustion processes during both
phases ofsmoke generation are comparable. However,
this is notthe case, asindicated bythe higher SS values
for CO (2.5-4.7), CO2 (8-11), acrolein (8-15), and ben-
zene (10), and for the pyrolysis products of nicotine:
pyridine (6.5-20), 3-methylpyridine (3-13), and 3-vi-
nylpyridine (20-40). The lower SS value for hydrogen
cyanide (0.1-0.25) also indicates that the generation of
MS and SS is governed by different combustion pro-
cesses. The higher SS yields of the reduction products
ofnitrate such as nitrogen oxide (4-10), ammonia (40-
170), methylamine (4.2-6.4), and especially the highly
carcinogenic N-nitrosodimethylamine (20-100) and N-
nitrosopyrrolidine (6-30) suggest higher toxicity and
carcinogenicity for undiluted SS than for MS.
Similarly, compared to MS, the particulate phase of
undiluted SS contains significantly higher amounts of
carcinogenic amines (2-toluidine, 2-naphthylamine, 4-
aminobiphenyl), carcinogenic hydrocarbons
(benz[a]anthracene, benzo[a]pyrene), and metals (cad-
mium, nickel, zinc).
Finally, it must be emphasized that the data in Table
2 are derived from analyses carried out under stand-
ardized laboratory conditions that may not fully reflect
the conditions prevailing in environmental settings,
which are influenced by such variables as puff-drawing
of the cigarette, room temperature, degree of ventila-
tion, and a number ofother factors. Another important
point is that MS emissions are significantly affected by
ifitration, while SS emissions are practicallyunchanged
bythe presence and natureofthefiltertipofacigarette.
Table 2. Distribution of compounds in cigarette mainstream
smoke (MS) and sidestream smoke (SS) for nonfilter cigarettes.a
MS Unit SS/MS
Vapor phase
Carbon monoxide
Carbon dioxide
Carbonyl sulfide
Benzene
Toluene
Formaldehyde
Acrolein
Acetone
Pyridine
3-Methylpyridine
3-Vinylpyridine
Hydrogen cyanide
Hydrazine
Ammonia
Methylamine
Dimethylamine
Nitrogen oxide
N-Nitrosodimethylamine
N-Nitrosopyrrolidine
Formic acid
Acetic acid
Particulate phase
Particulate matter
Nicotine
Anatabine
Phenol
Catechol
Hydroquinone
Aniline
2-Toluidine
2-Naphthylamine
4-Aminobiphenyl
Benz[a]anthracene
Benzo[a]pyrene
Cholesterol
y-Butyrolactone
Quinoline
Harman
N'-Nitrosonornicotine
NNK
N-Nitrosodiethanolamine
Cadmium
Nickel
Zinc
Polonium-210
Benzoic acid
Lactic acid
Glycolic acid
Succinic acid
aLiterature data (4,57-61).
10-23
20-40
18-42
12-48
160
70-100
60-100
100-250
16-40
12-36
11-30
400-500
32
50-130
11.5-28.7
7.8-10
100-600
10-40
6-30
210-490
330-810
15-40
1-2.5
2-20
60-140
100-360
110-300
360
160
1.7
4.6
20-70
20-40
22
10-22
0.5-2
1.7-3.1
200-3,000
100-1,000
20-70
100
20-80
60
0.03-0.5
14-28
63-174
37-126
110-140
mg 2.5-4.7
mg 8-11
,Lg 0.03-0.13
,ug 10
KLg 6
,ug 0.1-~50
,ug 8-15
,Lg 2-5
,ug 6.5-20
,Lg 3-13
,ug 20-40
,ug 0.1-0.25
ng 3
,ug 40-170
,Lg 4.2-6.4
iJg 3.7-5.1
,Lg 4-10
ng 20-100
ng 6-30
,ug 1.4-1.6
,Lg 1.9-3.6
mg 1.3-1.9
mg 2.6-3.3
,ug <0.1-0.5
gLg 1.6-3.0
,ug 0.6-0.9
,ig 0.7-0.9
ng 30
ng 19
ng 30
ng 31
ng 2-4
ng 2.5-3.5
tLg 0.9
Fg 3.6-5.0
,ug 8-11
,ug 0.7-1.7
ng 0.5-3
ng 1-4
ng 1.2
ng 7.2
ng 13-30
ng 6.7
pCi 1.03-3.7
,Lg 0.67-0.95
,ug 0.5-0.7
Fg 0.6-0.95
,ug 0.43-0.62
Air Pollution by Tobacco Smoke
The most widely monitored indoor pollutant origi-
nating from tobacco is carbon monoxide. In controlled
studies of enclosed spaces where machine-smoking oc-
curred inthe presence ofpeople, CO levelsranged from
24 to 220 ppm without ventilation and were lowered to
4 to 80 ppm with 6 to 8.5 air exchanges per hour (5).
Table 3 lists reported values for toxic and carcinogenic
tobacco smoke pollutants measured under natural con-
ditions. In most cases, the reported pollution levels for
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Table 3. Toxic indoor tobacco smoke pollutants measured under
natural conditions.a
Table 4A. Overall percentages of subjects reporting various
types and degrees of passive smoking (at least 1 hr/week).a
Pollutant
Nitrogen oxide
Nitrogen dioxide
Acrolein
Benzene
N-Nitrosodimethylamine
N-Nitrosodiethylamine
Anthanthrene
Benzo[a]fluorene
Benzo[ghi]perylene
Benzo[a]pyrene
Benzo[e]pyrene
Coronene
Fluoranthene
Perylene
Pyrene
Nicotine
Particulate matter
Location
Workrooms
Workrooms
Restaurants
Public places
Public places
Restaurants,
public places
Restaurants,
public places
Restaurants,
public places
Submarines
Public places
Restaurants
Workrooms
Airplanes
Taverns
Workrooms
Concentration
39-345 ,ug/rm3
50 Rg/m3
2-190 ,ug/m3
20-100 ,ug/m3
20-317 ,ug/m3
0.01-0.24 ,ug/m3
<0.01-0.2 ,ug/m3
0.5-3
39
5.9-17
2.8-760
ng/m3
ng/m3
ng/m3
ng/m3
15-35 ,ug/m3
1-6 Rg/m3
3-10 ,ug/m3
1-138 ilg/m3
< 120 kg/m3
330-980 p.g/m3
3-960 ,ug/m3
aFrom literature data (62-71).
the selected number of SS-derived agents in indoor air
exceed many times those reported for polluted urban
air. In the case of the volatile carcinogen nitrosodi-
methylamine, it has been calculated that the exposure
of a person in a highly smoke-polluted room is equiva-
lent, per hour, to that of an individual who inhales the
smoke of four to eight nonfilter cigarettes (6). .
It is generally believed, however, that cigarette
smoking is probably the single most important source
of indoor respirable particulate pollution. Friedman et
al. estimated that 63.3% ofadults were exposed to pas-
sive smoking for a least 1 hr/week (7). The exposure
decreased.with age. A higher percentage were exposed
out of the home, usually at work, than in the home
(Table 4). Repace and Lowrey estimated that average
exposure of the nonsmoking adult population to tars
from environmental tobacco smoke was 1.43 mg/day,
varying from 0 to 14 mg (8). The workplace appeared
to be four times as strong a source of exposure as the
home because ofthe greater smoking densitythere (Ta-
ble 5). A "typical cigarette smoker" would be exposed
to an average of 14 mg of tar per cigarette and 32 cig-
arettes or 442 mg of tar per day. Thus, the ratio of
active to passive smoking would be about 313 to 1.
Uptake of Smoke by Nonsmokers
The development of new biochemical methodologies
enables us to obtain more definitive measurements of
exposure to tobacco smoke by determining the uptake
of tobacco-specific compounds into body fluids and cal-
Passive smoking
exposure
Any
Home
Other small area
Large area
10+ hr/week, any
40+ hr/week, any
Total number
studied
34,861
35,169
35,201
35,135
34,861
34,861
Positive response
Number Percent
22,069 63.3
8,383 23.8
14,223 40.4
16,336 46.5
12,034 34.5
5,551 15.9
aData of Friedman et al. (7) by permission.
Table 4B. Distribution of total hours per week of any reported
passive smoking: sum ofthe hours in each of the three areas.'
Total hr per week Number Percent
0 12,792 36.7
1-9 10,035 28.8
10-39 6,483 18.6
> 40 5,551 15.9
Total 34,861 100.0
aData of Friedman et al. (7) by permission.
culatingthe healthriskrelativetothatofexposurefrom
active smoking. Some of these biochemical measure-
mentsofactivesmokingbehavior areapplicableto quan-
titating exposure by passive smoking.
Figure 1 demonstrates the association between cig-
arette smoking and the plasma levels ofnicotine, cotin-
ine, thiocyanate, and carboxyhemoglobin in whole
blood. Nicotine and its metabolite, cotinine, are specific
measures of tobacco consumption (9), while levels of
carboxyhemoglobin and thiocyanate can be influenced
by avariety ofenvironmental factors (10). Cotinine, the
major metabolite of nicotine, can be quantitated in
plasma, saliva, and urine. Its assessment has proven
helpful in differentiating smokers from nonsmokers
Table 5. Estimated probabilities of nonsmokers' exposure to
tobacco smoke at home and at work.a b
Lifestyle: daily average
probability of being
exposed (rounded values)
Exposure, mg
Modeled Daily
daily probability-
average weighted
At work and at home 63 x 62 = 39% 2.27 0.89
Neither at work nor at home 37 x 38 = 14% 0.00 0.00
At home but not at work 62 x 37 = 23% 0.45 0.10
At work but not at home 63 x 38 = 24% 1.82 0.44
Total 100 1.43
aThe estimated exposure to the particulate phase of ambient to-
bacco smoke for U.S. adults of working age, at work and at home
(these two microenvironments account for an estimated 88% of the
average person's-both smokers' and nonsmokers'-time), deter-
mined from average concentrations of tobacco smoke calculated for
modelworkplace and home microenvironments, weightedforaverage
occupancy. Nonexclusive probability ofbeing exposed at work, 63%;
probability of not being exposed at work, 37%. Nonexclusive prob-
abilityofbeingexposedathome, 62%;probabilityofnotbeingexposed
at home, 38%.
bData of Repace and Lowrey (8) by permission.
59KULLER ET AL.
301
201
10
(25)
(19) (32)
(22) (90) (43) (47)
L. (24)
(97)
(47),
{.(21
(34)
--- 9
a a
1-10 11-15 16-20 21-25 26-30 >30
200
(24)
(32)
(42)
50
I
I
(88)
a I I
1-10 11-15 16-20 21-25 26-30 >30 1-10 11-15 16-20 21-25 26-30 >30
CPD
FIGURE 1. Plasma parameters ofcigarette smoke absorption as a function ofdaily numbers ofcigarettes consumed (CPD). Data given as the
total population smoking all brands ofcigarettes (9). Reprinted with permission.
even at low levels of daily cigarette use (11). Changes
in smokingbehavior orcompensation as smokersswitch
to low-yield cigarettes can be effectively monitored by
measurements of plasma cotinine.
Both nicotine and carboxyhemoglobin have short cir-
culating half-lives such that measurement ofthese com-
pounds limits theirreliability to assess only very recent
use ofcigarettes (9). Cotinine has arelatively long half-
life, is specifictotobacco exposure, and canbemeasured
at low levels in biological fluids. Currently, this mea-
surement provides the best index of exposure to envi-
ronmental tobacco smoke, as well as of active smoking
behavior.
The uptake of nicotine and its metabolic conversion
to cotinine in nonsmokers has been investigated under
controlled conditions in exposure chambers (1,12) and
in free-living situations among adult (13,14) and pedia-
tric (15) populations.
To investigate uptake under controlled conditions, a
laboratory was constructed to expose nonsmoking sub-
Table 6. Test laboratory.a
Size 16.3 me
Temperature 22 ± 10C
Air exchange 6 times per hr
Pollutants Sidestream smoke offour concur-
rently smoked lRl reference cig-
arettes
Indoor pollution
Particulate matter 4,600 ,ug/m3
Nicotine 280 ,ug/m3
Hydrogen cyanide 56 ,ug/m3
Carbon monoxide 25 ppm
NO. 0.91 ppm
Formaldehyde 160 ,ug/m3n
aData ofHoffmann et al. (12) bypernission.
jects to sidestream smoke while exhausting the main-
stream smoke from the room (12). The characteristics
of this laboratory and pollution levels observed in it
during the simultaneous smoking offour cigarettes are
presented in Table 6. Nonsmoking volunteers remained
E
C
z
0
0
z
---
0IR
0
0
4
60
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Table 7. Cotinine and nicotine levels in saliva ofvolunteers
exposed to sidestream smoke.',b
2 Cigarettes' 3 Cigarettes 4 Cigarettes
Time, Nicotine, Cotinine, Nicotine, Cotinine, Nicotine, Cotinine,
mnin ng/mL ng/mL ng/ lmL ng/mL ng/mL
Base- 8 1.2 1 1.7 3 1.0
line
E 20 372 7.0 505 0.3 458 1.3
E 40 347 0.3 712 2.5 825 1.1
E 60 427 0.8 837 5.0 878 2.1
E 80 386 2.3 893 2.5 730 1.4
+30 76 2.3 157 1.5 148 1.7
60 26 1.0 46 3.3 49 1.4
90 13 1.5 26 2.3 31 2.7
120 6 1.5 17 2.8 23 2.5
150 3 2.5 9 2.3 17 3.1
180 13 3.3 14 2.0 24 2.8
210 5 1.5 12 3.5 6 2.0
240 8 5.0 2 1.3 3 1.9
270 6 3.3 4 2.0 6 2.3
300 7 1.0 7 1.0 7 3.5
aE = Exposure to sidestream smoke in 16 m3 chamber.
bData of Hoffmann et al. (12) by permission.
eNumber ofcigarettes being smoked throughout the exposure pe-
riod.
in the room for 80 mn, while saliva and blood samples
were collected at 20-mn intervals during exposure and
for5 hrafter leavingthe chamber. Tables 7-9 showthe
analyticalprofiles ofmarkers oftobaccosmoke exposure
in saliva, plasma, and urine. Thiocyanate and carboxy-
hemoglobin levels were not significantly elevated invol-
unteers following exposure. Nicotine was barely in-
creased in plasma, but its metabolite, cotinine, was
significantly elevated 2-3 hr after the start of the ex-
posure. In saliva, nicotine levels rose rapidly to about
Table 8. Cotinine and nicotine levels in plasma ofvolunteers
exposed to sidestream smoke.a,b
2 Cigarettes' 3 Cigarettes 4 Cigarettes
>, Nicotine, Cotinine, Nicotine, Cotinine, Nicotine, Cotinine,
ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL
1.1 1.7 NDd 1.0 0.2 0.9
0.2
ND
ND
1.1
0.2
0.2
0.6:
1.5
0.2
ND
ND
ND
0.9
ND
2.2 1 0.8 ND
1.5 2.1 0.8 0.3
1.3 4.2 0.7 0.3
1.8 1.3 1.1 0.5
1.8 2.7
1.9 0.6
2.3 2.9
1.7 0.3
1.4 0.7
2.6 0.2
1.8 0.7
2.1 0.2
2.1 0.2
ND
1.2
0.9
1.2
1.3
1.6 0.4 1.8
2.1 0.8 2.1
1.9 0.6 2.6
2.1 1.4 2.9
2.6 0.7 2.9
3.0 1.0 3.3
2.0 0.2 3.3
1.9 1.1 3.3
2.4 0.6 3.4
2.5 0.6 3.2
Table 9. Cotinine and nicotine levels in urine ofvolunteers
exposed to sidestream smoke.ab
2 Cigarettesc 3 Cigrettes 4 Cigarettes
Time, Nicotine, Cotinine, Nicotine, Cotinine, Nicotine, Cotinrne,
min ng/mL ng/mL ng/mL ng/mL ng/mL ag/mL
Base- 24 14 20 14 17 14
line
E 80 26 16 34 21 84 28
+150 40 21 94 34 100 46-
300 51 21 58 38 48 55
aE = Exposure to sidestream smoke in 16m3 ehamber;
bData ofHoffmann et aL(12) bypermisso.
'Number ofcigarettes beingsmoked throughout the exposure pe-
riod.
800 ng/mL. They quickly subsided after the volunteers
left the room. When the volunteers were exposed to
the pollutants oftwo, three, or fourcigarettes, a dose-
response relationship for nicotine in s-aliva and cotini-ne
in urine was observed. Further studies ofthis type con-
firmed the presence of cotinine in the urnme of non-
smokers.
In a study ofpatients attending an outpatient clinic,
Jarviset al. (13) foundthattheconcentrationofcotini-ne
in body fluids was related to self-reported exposure to
sidestream smoke. Salivarynicotineconcentrations cor-
responded to the dose when exposure and testing oc-
curred on the same day, but measures of thiocyanate
and expired carbon monoxide were unrelated to the
dose. AsummaryofthedatabyJarvisetal. ispresented
in Table 10.
A similar study in Japan (14) examned exposures at
homeandintheworkplaceandrevealedadose-response
relationship for cotini-ne excreted into the urine. The
presence of smokers both in the home and at work el-
evatedthecotininelevelswithincreased exposure time.
An arbitrary designation oftobacco smoke density (not
smoky, smoky, frequentlysmoky) aswellasthenumber
of smokers at a given site were related to increased
cotinine tocreatinine excretionratiolevelsgreaterthan
those noted by researchers in the United States or in
England (this discrepancy is believed to be methodo-
Table 10. Measurement-s ofself-reported pasgive smoking.a
None A little Some A lot
(r= 46) (n = 27) (r= 20) (n = 7) pValue
Expired CO, ppm 5.7 5.6 5.6 5.4Q NS
COHb, % 0.94 0.81 0.80 0.80 NS
Nicotine, ng/mL
Plasma 1.04 0.76 0.72 0.90 NS
Saliva 3.81 4.80 4.44 12.12 <0.05
Urine 3.87 12.12 11.92 12.12 = 0.06
Cotiniine, ng/mL
Plasma 0.82 1.81 2.52 1.81 < .005
Saliva 0.73 2.20 2.80 2.63 <0.001
Urine 1.55 6.50 8.65 9.36 < .001
Thiocyanate
Plasma, 4.81 5.55 5.51 47.4 NS
p.mole/L
Saliva-mmole/L 1.27 1.50 1.03 1.51 NS
Urine, u;mole/L 72.8 803: 74.2 73.1 NS-
aData ofJarvis et al. (13)7by perission.
Time
min
Base
line
E20
E 40
El60
E80
+-30
60
90
120
150
180
210
240
270
300
aE = Exposure to sidestrearn smoke in 16 m3 chamber.
bData ofHoffmann et al. (12) by permission.
'Number ofcigarettes bei-ng smoked throughout theexposure pe-
riod.
'ND- = not detected-.
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FIGURE 2. Relation between the number of cigarettes smoked by
mothers in the previous 24 hr and the urinary concentrations of
cotinine in their infants (17). Reprinted with permission.
logical in nature). This study did confirm, however, the
utility of urinary cotinine to creatinine ratios in evalu-
ating uptake of nicotine by nonsmokers.
Wald et al. reported median urinary cotinine levels
of 1645 ng/mL in cigarette smokers as compared to 6
ng/mL innonsmokers exposed toenvironmentaltobacco
smoke and 2 ng/mL in those not exposed (16). The co-
tinine levels in exposed nonsmokers increased substan-
tially with the amount of exposure. The average meas-
ures represent a ratio of active to passive smoke
exposure of411, but this does notimplythat cancerrisk
will necessarily be in the same ratio.
Greenberg et al. (17) measured the concentrations of
nicotine and cotinine in the saliva and urine of infants
with and without reported exposure in the household.
The concentrations of both compounds were signifi-
cantly higher in the exposed group than in the group
without exposure. The best indicator of chronic expo-
sure was the urinary cotinine to creatinine ratio, with
a direct relationship between cotinine excretion by the
infants and the self-reported smokingbehavior ofmoth-
ers during the previous 24 hr (Fig. 2).
The results of chamber studies as well as free-living
evaluations ofnonsmokers exposed tosidestreamsmoke
suggest that measurement ofurinary cotinine excretion
can provide a reliable, objective indicator of exposure
to sidestream smoke.
In summary, there is no question that individuals are
exposed to environmental tobacco smoke. Although
such exposure maybe relatively low compared to active
cigarette smoking, uptake of environmental tobacco
smoke pollutants begins very early in life and is directly
related to the degree of exposure. The degree of ex-
posure is a function of the number of persons contrib-
utingtosmokepollution, theamountoftobaccoproducts
Table 11. Occurrence of five major types of lung cancers in
smokers and nonsmokers.'
Male Female
Never Never
Type Total Smoker smoker Smoker smoker
Epidermoid 992 892 7 80 13
Smal cell 640 533 4 100 3
Adenocarcinoma 760 492 39 128 101
Large cell 466 389 16 46 15
Bronchioloalveolar cell 68 35 4 13 16
Total 2926 2341 70 367 148
'Data of Rosenow andCanr (18) by permission.
being smoked, and the dimensions and ventilation char-
acteristics oftherooms and buildings inwhichexposure
occurs, as well as the duration of exposure.
Risk of Lung Cancer
The relationship of the risk of lung cancer to envi-
ronmental tobacco smoke has been studied in classic
case-control and longitudinal studies. Most ofthe stud-
ies have measured the risk of lung cancer or the odds
ratio among nonsmoking lung cancer cases, usually
women, in relationship to the smoking habits of the
spouse, parents, orco-workers. Onlyafewstudieshave
included men or smokers as index cases. It is important
to note that most lung cancer cases in men occur in
current or former cigarette smokers and that a high
percentage of lung cancers occurring among nonsmok-
ers, especially women, are predominantly adenocarci-
nomaratherthan epidermoid carcinoma. The estimated
incidence of lung cancer among both men and women
who were lifetime nonsmokers was only about 10 per
100,000.
In the large series in the Mayo Clinic, only 70 cases
(3%) oflungcancerinmenoccurred amongnonsmokers,
and apparently 55% of the 70 cases were adenocarci-
noma (Table 11). Amongwomen, 148 of515 cases (29%)
occurred among nonsmokers, and 68% were adenocar-
cinoma (18). Similar results are recently reported by
Kabat and Wynder (Table 12) (19). Community studies
in New Orleans (20), as well as in Allegheny County,
PA (21), have reported a very low frequency of lung
cancer among nonsmoking men. Therefore, it is prob-
ably unlikely that passive smoking accounts for a sub-
stantial portion of epidermoid carcinoma of the lung,
eventhoughreported relative risks forepidernoid lung
cancer associated with passive smoking may be as high
or higher than for adenocarcinoma.
At most, there were only about3000 new lungcancer
cases among nonsmoking men in the United States in
1984, and at least halfwere probably adenocarcinomas.
Among women, on the other hand, up to 20% or more
oflung cancers may occur among nonsmokers, perhaps
6000 to 8000 a year, but again 4500 of those 6000 are
probably adenocarcinomas.
Independent estimates of nonsmokers dying of lung
cancer have been made by H. Seidman ofthe American
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Table 12. Histologic type of lung cancer in never smokers and
smokers.a
Men Women
No. % No. S
Never smokers
Kreyberg type I 13 (35.1) 20 (20.6)
Epidermoid/squamous 13 (35.1) 16 (16.5)
Large cellgiant cell 0 4 (4.1)
Kreyberg type II 20 (54.1) 72 (74.2)
Adenocarcinoma 16 (43.2) 60 (61.9)
Alveolar 4 (10.8) 12 (12.4)
Mixed (Kreyberg I and 4 (10.8) 5 (5.2)
II) and undifferen-
tiated/anaplastic
Total 37 97
Smokers
Kreyberg type I 1187 (63.1) 341 (52.3)
Kreyberg type II 600 (31.9) 279 (42.8)
Mixed (Kreyberg I and 95 (5.0) 32 (4.9)
II) and undifferen-
tiated/anaplastic
Total 1882 652
aData of Kabat and Wynder (19) by permission.
Cancer Society. Five-year lung cancer death rates of
smokers in 1967 to 1971 from the American Cancer So-
ciety's prospective study have been extrapolated to the
present, assuming nonsmokers' rates did not increase.
These extrapolated rates were then applied to esti-
mated 1985 populations according to the distribution of
smokers andnonsmokersby ageintheAmerican Cancer
Society's prospective study, Cancer Prevention Study
II. Deaths were adjusted to comply with the American
Cancer Society's estimates oftotal lung cancer in 1985.
The American Cancer Society estimated that 2900 men
and 6200 womennonsmokers died oflung cancerin 1985.
An unknown proportion ofthese may be due to passive
smoking.
Studies relating environmental tobacco smoke expo-
sure and lung cancerrisk are described in Tables 13 and
14. These studies include cohort studies and a number
ofcase-control studiesthat comparenonsmoking women
with lung cancer to nonsmoking women with other dis-
eases. These studies seem to indicate that passive
smoke exposure plays a role in causing cancer in non-
smoking women. However, individually, each of these
studies-positive or negative-suffers methodologic
weaknesses. The problems of greatest concern are the
possibility ofmisclassification ofboth active and passive
smoking status, misclassification of tumor pathology,
use of inappropriate controls, and small sample sizes.
Misclassification of Exposure
Misclassification of exposure has been an overwhelm-
ing concern ofthe critics ofthe published studies. This
has been especially true for the studies done in Japan
(22-24) and Greece (25), where surprising numbers of
cancers were seen in nonsmokers. The possibility of
"closet smoking" by these nonsmoking women married
to smokers has been suggested but has never been con-
firmed. However, ifitistruethatfewJapaneseorGreek
womensmoke, itisnotsurprisingthatfewofthewomen
with lung cancer are smokers. This does not indicate a
problem with these studies unless there are more can-
cersthancouldbeexpectedinanonsmokingpopulation.
Misclassification is perhaps of greater concern in some
of the other studies where the reported relative risks
and sample sizes have been smaller (20,26-29) and
therefore more likely to change with a small amount of
misclassification.
Recall bias in reporting passive smoke exposure is
also a major potential problem in the case-control stud-
ies. Childhood smoke exposure histories were validated
in the North Carolina study, and there did not appear
to have been differential recall (30). Similar data are
not available for smoking by a spouse. In the cohort
studies, changes in exposure status over time rather
than differential misclassification of passive smoke ex-
posureisofconcern. Otherstudies, suchasthatinHong
Kong (26), have obtained information only on current
cigarette smoke exposure, and thus persons with past
exposures may be misclassified.
Misclassification of Pathology
Concerns about misclassification of tumor pathology
are closely linked with concerns about misclassification
ofsmoking status. Trichopoulos et al. attempted to ex-
cludeadenocarcinomas, but77ofthe 102remaininglung
cancers were among nonsmokers (25). This is a much
largerproportion ofnonsmokersamongepidermoidcan-
cer patients than would be expected from U.S. data.
One possible explanation is that women in the Tricho-
poulos et al. study were in fact smokers. Alternatively,
because pathologic confirmation was not always avail-
able and available data were not systematically re-
viewed, these cases may be misclassified according to
lung pathology. In fact, none of the studies included
independentreview ofpathology, and classification may
beaffectedbyindividualvariationsininterpretationand
changes over time in standards. An exception is the
study of Garfinkel et al. in which the histology of both
cases and controls was reviewed (31).
Sample Size
In many ofthe studies, there are too few nonsmoking
lung cancer cases to produce reliable estimates of the
relativerisk. Forexample, someAmerican studieshave
involved 22 lung cancers, of which only two were in
nonsmokers (30,32); 35lungcancers innonsmokers (20);
and 29 nonsmoking cases in another study (27).
A new American study in four hospitals over an 11-
yr period, 1971 to 1981, includes 134 nonsmoking lung
cancer cases and 402 controls. All cases and controls
were verified histologically. A dose-response relation-
ship oflung cancer was found in relation to the number
of cigarettes the husband smoked at home (31).
Sample size can also be a problem for cohort studies.
Otherthanthe studiesbyHirayama(22-24), therehave
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Tale 13. Passive smeke exoure in adulthood and cancer risk: case-control studies of lung cancer.
Study Casesa Control Exposure Risk
Greece (25) 77 ns females 225 ns female orthopedic Spouse 1.9 light-smoking spouse
patients 2.5 heavy-smoking spouse
Hog Kong (26) 84 ns females 139 ns female orthopedic Spouse 0.8 current smoking by spouse
patients
Loiana (20) 10 us males 180 ns male hospital patients Spouse 2.0 males or females
25 ns females 133 ns female hospital patients with smoking spouse
("non-smoking-related" 1.5 both sexeswithlight exposure
diseases) 3.1 both sexes with heavy
exposure
Multi-Center USA (19) 37 us males 37 ns male hospital patients Spouse 1.3 males exposed at home
97 ns females 97 ns female hospital patients home 3.3 males exposed at work
("non-smoking-related" work 0.9 females exposed at home
diseases, 0.7 females exposed at work
62% other cancers)
North Carolina (30, 32) 15 males, s and ns 159 male acquaintances or Spouse 1.9 males with spouse exposure
population controls (spouse) 00 females with spouse exposure
7 females, s and ns 330 female acquaintances or
population controls
(08 cases all sites) (489 acquaintances or population (1.6 spouse ever smoked)
controls)
New Jersey, Ohio (31) 134 ns females 402 ns females with colon cancer Spouse 1.2 odds ratio
CAlifornia (27) 149 females- matched neighborhood controls Spouse 1.2 adenocarcinoma, spouse
adenocarcinoma (50% work 1.3 adenocarcinoma, work
ns) 1.0 squamous cell carcinoma,
71 femles-squamous spouse
cellcarcinoma,(almost 2.3 squamous cell carcinoma,
all smokers) work
Pennsylvania (36) 123 us female deaths 414 ns female-deaths Spouse 1.4 all women with smoking
from lung cancer other causes spouse
1.9 unemployed women with
smoking spouse
West Germany (35) 39 ns females "population estimate" Spouse 2.0 to 3.0
prevalence of smoking
by married males
Hong Kong (28) 200 females 200 population controls Spouse 0.51 smokers
work 1.24 nonsmokers
Hong Kong (29) 88 females 137 district controls Spouse 2-3 times higher risk
Japan (72) 19 males 110 male controls Spouse 1.8 males
94 females 270 female controls 1.5 females
as nonsmoker; s = smoker.
been few cohort studies large enough to evaluate lung
cancerriskfrompassive smoking. The studyinScotland
by Gillis et al. (33) had a very small sample size and a
short follow up period. Some relationship between en-
vironmental tobacco smoke and lung cancer was seen
for men but not women. The study, however, lacked
sufficient power to detect a risk for women. The Amer-
ican Cancer Society's cohort study had a large sample
but minimal information about environmental tobacco
smoke exposure (34). A small but inconsistent relation-
ship with husband's smoking was observed.
Choice of Controls
Choice of appropriate comparison groups is always
difficult but may be especially difficult for studies of
exposure to cigarette smoke. Trichopoulos et al. (25)
used orthopedic patients as controls, presumably be-
cause this might be one diagnosis not related to ciga-
rette smoking. However, controls were from adifferent
hospital than were cases, and it is unclear what prob-
lems thismight introduce. The studies by Sandler et al.
(30,32) used acquaintances ofcasesascontrols, butthey
were notsuccessfulinobtainingcontrolsforallsubjects.
Thus, a second group of random controls was added.
While these different groups do not appear to have af-
fected the results, it is possible that some differences
have been overlooked. Knoth et al. (35) did not use
controls at all but inferred a population exposure from
dataonsmokingbymalesindifferent agegroups. Miller
(36) neglected to control for age differences between
cases and controls. Such adjustment would probably
invalidate thereportedpositive associationwithpassive
smoking.
Some studies have used other cancer cases as con-
trols. The recently completed American Cancer Society
study used colorectal cancer patients as controls (31).
One report suggested that colorectal cancer risk may
be decreased amongsmokers (37), althoughthis has not
been foundin many otherstudies. ThemulticenterU.S.
study used all other cancers for comparison, some of
whichmayberelatedtobothactiveandpassivesmoking
(19,38) and may, therefore, underestimate risk from
passive smoke exposure. This may be more true for
.aAPASSIVE SMOKING AND LUNG CANCER
Table 14. Passive smoke exposure in adulthood and cancer risk: prospective studies.
Study Populationa Exposure Outcome Risk
Japan (22-23) 91,540 ns females Spouse Total mortality 1.45 lung cancer
1966-1981 Lung cancer 1.1 all sites
Other cancers (other causes with
increased risk:
emphysema, nasal sinus
cancer, brain cancer)
Japan (24) 20,289 ns married males Spouse Lung cancer 2.25
1966-1981
Scotland (33) 4,067 maried males Spouse Total mortality 1.0 all causes, s and ns males
4,061 married females Lung cancer 1.5 all causes, ns females
1972/6-1982 Other cancers 3.3 lung cancer, ns males
Noncancer deaths 1.0 lung cancer, ns females
USA (34) 176,739 ns married females Spouse Lung cancer mortality 1.3 light-smoking spouse
1960-1972 1.1 heavy-smoking spouse
Amsterdam (41) 1,007 married couples Spouse Total mortality No consistent risk
25-year follow-up
California (39) 695 ns married females Spouse Total mortality 1.2 total mortality
1974-1983 IHD mortality 2.3 IHD
MRFIT (40) 1,245 ns married males Spouse Total mortality 2.0 increased risk, total
1972/4-1982 CHD mortality mortality
2.1 increased risk, CHD
mortality
ans = nonsmoker; s = smoker.
females than for males, where sites such as the cervix
have been increasingly linked with both active and pas-
sive smoke exposure.
Other Cancers and Chronic Diseases
Several other studies have examined total mortality,
cardiovascular disease, and cancers of nonrespiratory
sites. These studies aregenerallypreliminary innature.
Garland et al. reported an excess ofischemic heart dis-
ease deaths among nonsmoking women exposed to to-
bacco smoke, but the study was quite small, and the
risks were unstable (39). Preliminary results of the
follow-up of never-smoking or nonsmoking men in the
Multiple Risk Factor Intervention Trial have shown ex-
cesses ofboth total and coronary heart mortalityamong
men whose wives smoked, as compared to those whose
wivesdidnotsmoke(40). Otherstudies (24,33)alsooffer
some support for a possible effect of passive smoking
on heart disease risk. Vandenbroucke et al. reported
ontotalmortalityinrelationtopassivesmokeexposure,
but the study was too small to identify any real effects
(41). Furthermore, women married to ex-smokers were
considered nonexposed, which may have limited the
likelihood of observing any effects. In a study to eval-
uate cancer risk from childhood exposures, which also
included data on spouse smoking, a significant associ-
ationwithnonrespiratorysiteswasobserved(32). How-
ever, the study was not able to control for many known
risk factors orpotential confounding factors for cancers
of specific sites. Hirayama (23) has also observed as-
sociations between spouse's smoking and nonrespira-
tory tract cancers but did not obtain data on many po-
tential confounding variables.
Childhood Exposures
Cigarette smoke exposure also occurs in early life,
andmothers' orfathers'smokingmaybeassociatedwith
increased cancer risk in childhood or even adulthood.
Data from recent biochemical studies indicate that chil-
dren of mothers and fathers who smoke are meaning-
fully exposed in utero and in childhood to the potential
carcinogens in cigarette smoke (15,34,37,39-47). Stud-
ies in animals ofeffects ofexposure to particular chem-
icals, including some that are in cigarette smoke, sug-
gest that these chemicals may be transplacental
carcinogens for humans and that effects oftransplacen-
tal or early life exposures may be greater than effects
fromsimilarlevels ofexposurelaterinlife (48-51). Fur-
thermore, animal studies also suggest that resulting
tumors may include multiple sites and may be of adult
morphology (49).
In a large retrospective study of childhood cancers,
Stewart et al. (52) observed a small but significant rel-
ative risk associated with mother's cigarette smoking
duringpregnancy. In asmaller prospective study, Neu-
tel and Buck (53) reported a 30% increase in risk of
childhood cancer associated with mothers' smokingthat
wasnotquite statisticallysignificant. Case-controlstud-
ies of individual childhood tumors have also reported
positive associations with parents' smoking (54-56), al-
though other studies do not report such effects. These
studies are summarized in Table 15.
Studies in animals alsosuggestthat someeffectsfrom
early life exposures may not be apparent until adult life
(47). Iftrue, this suggests that some studies ofparents'
smoking and childhood cancers might be negative be-
cause an effect might not be apparent until adulthood.
Epidemiologic studies in humans have recently sug-
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Table 15. Cancer risk and parental smoking: selected studies of
children and young adults.
Study Designa Cancer site Age Risk
Preston-Martin C/C Brain to 25 1.5 fathers
(54) during
pregnancy
Henderson (73) C/C Testis to 40 1.0 mothers
Gold (56) C/C Brain to 20 5.0 smoking
mothers
who
continued in
pregnancy
Manning (74) C/C Leukemia to 15 1.0 mothers
Stewart (52) C/C All to 10 1.1 mothers
Neutel (53) cohort All to 10 1.3 mothers
during
pregnancy
Grufferman (55) C/C Rhabdomyo- to 15 3.9 fathers
sarcoma during
pregnancy
1.0 mothers in
pregnancy
aC/C = case-control study.
gested the possibility of an association between trans-
placental or early life exposure to cigarette smoke and
adult cancers, including cancers ofthe respiratory tract
and other nonrespiratory sites, although these studies
must be considered preliminary (20,27,32) (Table 16).
Conclusions
The relationship ofenvironmental tobacco smoke and
disease, specifically lung cancer and possibly other res-
piratory tract cancer, is important. First, there are ob-
vious publichealthimplications, giventhatperhaps 60%
of the population is exposed to environmental tobacco
smoke. Second, confounding of environmental tobacco
smoke exposure with other environmental and occu-
pational risks is possible. Third, information learned
about passive smoking may help increase our under-
standing of the relationship between long-term expo-
sures torelatively lowdose carcinogens and subsequent
disease.
A greater number oflung cancers in nonsmokers are
found in women, and studies to date, although not con-
clusive, indicate that environmental tobacco smoke is
probably related to lung cancer in women. It is unlikely
Table 16. Cancer risk and parental smoking: adults.
Study Designa Cancer site Risk
Correa (20) C/C Lung 1.7 mothers
1.0 fathers
(adjusted for own
smoking)
1.4 mothers, 0.8 fathers
Sandler (32) C/C All 1.1 mothers
1.5 fathers
Wu (27) C/C Lung 1.7 mother, adenocarcinoma
1.3 father, adenocarcinoma
0.2 mother, squamous cell
0.9 father, squamous cell
aC/C = case-control study.
that a significant effect ofenvironmental tobacco smoke
andactivecigarettesmokingsynergisticallycanbeiden-
tified from most ofthese epidemiologic studies.
Exposures veryearlyinlifeto environmental tobacco
smoke may be important in relationship to the subse-
quentdevelopmentofcancerandneed tobe considered.
Only a few studies to date have evaluated the relation-
ship between environmental tobacco smoke and sub-
sequent childhood cancers, and almost none have eval-
uated cancers that occur in adulthood. The short-term
effects of environmental tobacco smoke on the cardio-
vascularsystem, especiallyamonghigh-riskindividuals,
may be of even greater concern than that of cancer.
Further study of the increased risks of lung cancer
in relation to environmental tobacco smoke exposure
willrequire largercollaborative studiestoidentifymore
lung cancer cases among noncigarette smokers, better
delineation of pathology, and more careful selection of
controls.
Finally, it may be possible to consider studies ofepi-
thelial cells or specific cytology to determine at least
evidence of cellular changes in relationship to environ-
mentaltobaccosmokeexposure. Environmentaltobacco
smokeexposureismostlikelythemostimportantindoor
air pollutant.
Research Recommendations
Epidemiologic Studies
Recommendation 1: There should be continued ef-
forts to measure individual exposures to passive smok-
ing. At present, measurement of urinary cotinine ap-
pears to be the best method. Other chemicals should be
evaluated as well as specific biological markers. Per-
sonal direct monitoring should have high priority.
Recommendation 2: Additional case-control stud-
ies areneededtoevaluatetherelationshipbetweenpas-
sive smoking and lung cancer. Such studies should in-
clude primary noncigarette smokers with lung cancer
patients as cases and appropriate controls. It is impor-
tant that these studies include a broad age range; spe-
cificpathologicaltypeoflungcancer; andcarefulrecords
ofthe history ofcigarette smoking in parents, spouses,
at-work environment, other possible risk factors, oc-
cupation, and environmental exposure.
Recommendation3: Case-control studiesshouldbe
done to investigate the possible association between
passive smoke exposure in childhood and adulthood and
riskforcancerofothersites. Suchstudiesshouldinclude
attention to otherknownriskfactors forcanceratthese
sites and include data on relevant confounding factors.
Differences between sidestream smoke and main-
stream smoke-such as the higherlevels ofspecific car-
cinogens in fixed volumes of sidestream smoke versus
mainstream smoke, smaller particle size, and the pos-
sible different depositioninthe lung-suggestthatpas-
sive smoke exposure may not be just a lower dose of
active smoke exposure. Passive smoking results in pos-
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sible systemic exposures. Preliminary studies have re-
ported associations between passive smoke exposure
and nonrespiratory tract sites.
Studies of the health effects of cigarette smoke ex-
posure should attempt to identify a truly nonexposed
comparison group. While active smokers are also pas-
sive smokers, health effects that are specific to side-
stream smoke cannot be identified in studies ofsmokers
versus nonsmokers where nonsmokers also include pas-
sive smokers.
Recommendation4: Childhood cancers and suscep-
tibility to adult cancers should be evaluated in light of
early life exposure to passive smokingorto mainstream
smoke in utero. Childhood exposure to passive smoking
can begin in utero, where the fetus is exposed to the
mainstreamsmokeinhaledbythemother. Exposure can
continue through infancy and childhood as sidestream
smoke generated by the parents, caretakers, or asso-
ciated adults is absorbed by the child. The absorption
of nicotine by infants has been shown to be dose re-
sponsiveandcanresultinhighlevelsofurinarycotinine.
Recommendation 5: If possible, a cohort longitu-
dinal study of passive smoking and lung cancer should
be done. The sample size would require about 100,000
middle-aged women with an average cancer risk of 10
per 100,000 per year, followed for up to 10 years. Such
large cohorts already exist (NCI breast cancer screen-
ing studies, NHLBI cohorts, etc.). In any such study,
an attempt should be made in all these studies to build
in some measure of passive smoking, such as urinary
cotinine, as well as history of exposure. The cotinine
could be measured in a nested case-control study.
Recommendation 6: A specific case-control study
ofwell-documented adenocarcinoma ofthe lung should
be done. Variables to be studied should include active
smoking, passive smoking, environmental exposures,
family history, diet (i.e., vitamin A, carotene), alcohol
intake, and other cancers in the case, as well as the
family. Validationofthepathologicaldiagnosis iscritical
in such studies.
Recommendation 7: The distribution of exposure
topassive smokingindifferentpopulationgroupsshould
be described by various sampling strategies using ex-
isting population study sources and measurement of
passive smoking by urinary cotinine and other suitable
markers.
Recommendation 8: If possible, the type of study
ofbronchialepithelialchangesinpostmortemspecimens
should be done for noncigarette smokers with attention
to passive smoking exposures.
Experimental Studies
Recommendation 9: If possible, the relationship
between sidestream smoke exposure or mainstream
smoke exposure with lung cancer should be evaluated
in animal models. Experimental studies could be par-
ticularly useful in elucidating such issues as the relative
risks oftransplacental versus childhood exposures and
their importance to the development oflung cancer.
Recommendation 10: Long-term animal inhalation
studies with passive smoke are needed. It is recom-
mendedthat suchstudiesbedoneintwoanlimalspecies,
preferably rats and Syrian golden hamsters. Emphasis
should be placed on the induction oftumors in the res-
piratorytractand otherorgans. Earlyhistopathological
changes in the respiratory tract should be investigated
in these assays.
Recommendation 11: Animal inhalation studies
withpassive smoke should alsobe initiated withrespect
to transplacental carcinogenesis. Detailed biochemical
research is required.
Recommendation 12: In-depth studies are needed
to clearly delineate the differences in the physical na-
tures and chemical compositions of sidestream and
mainstream smoke. It has been established that the
physiochemical nature ofpassive smoke, the smoke in-
haled by nonsmokers, differs significantly from the
mainstream smoke inhaled by the active smoker. Data
are needed to delineate these differences.
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